Lymphoma

Featured Lymphoma Content

Recent Advances in Management of Relapsed Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma

Oncologist Michelle Fanale, MD, and oncology nurse Rinata Simien, RN, NP-C, discuss the clinical treatment options for patients with relapsed Hodgkin lymphoma and anaplastic large cell lymphoma.

Lymphoma News & Features

Nicotinamide Supports NK Cellular Therapy in NHL

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date August 21, 2023

Researchers sought to determine whether expansion of NK cells with IL-15 and nicotinamide would improve responses in patients with NHL and MM.

Pembrolizumab Induces Long-Term Response in Relapsed, Refractory PMBCL

By

Jonathan Goodman, MPhil

Publish Date August 9, 2023

Researchers sought to determine whether pembrolizumab would induce long-term responses in heavily pretreated patients with relapsed or refractory PMBCL.

Body Composition Can Change During Chemo in Young Patients With Lymphoma, Rhabdomyosarcoma

By

Ryner Lai, MBBS

Publish Date July 25, 2023

Young patients with lymphoma or rhabdomyosarcoma may experience changes in body composition during chemotherapy, research suggests.

CLL Treatment Affects ICI Efficacy in Patients With Melanoma and CLL

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date July 24, 2023

Treating advanced melanoma with immune checkpoint inhibitors can be safe and effective in patients with concomitant CLL, a study suggests.

Next-Generation BTK Inhibitor Orelabrutinib Shows Efficacy in Relapsed/Refractory MZL

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date June 29, 2023

Researchers sought to determine whether orelabrutinib would be effective in patients with relapsed/refractory MZL.